1. Home
  2. OCEA vs YYAI Comparison

OCEA vs YYAI Comparison

Compare OCEA & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCEA
  • YYAI
  • Stock Information
  • Founded
  • OCEA 2019
  • YYAI 2015
  • Country
  • OCEA United States
  • YYAI Hong Kong
  • Employees
  • OCEA N/A
  • YYAI N/A
  • Industry
  • OCEA Biotechnology: Pharmaceutical Preparations
  • YYAI
  • Sector
  • OCEA Health Care
  • YYAI
  • Exchange
  • OCEA Nasdaq
  • YYAI NYSE
  • Market Cap
  • OCEA 20.5M
  • YYAI 19.1M
  • IPO Year
  • OCEA N/A
  • YYAI N/A
  • Fundamental
  • Price
  • OCEA $0.54
  • YYAI $0.83
  • Analyst Decision
  • OCEA
  • YYAI
  • Analyst Count
  • OCEA 0
  • YYAI 0
  • Target Price
  • OCEA N/A
  • YYAI N/A
  • AVG Volume (30 Days)
  • OCEA 617.7K
  • YYAI 367.5K
  • Earning Date
  • OCEA 01-13-2025
  • YYAI 03-04-2025
  • Dividend Yield
  • OCEA N/A
  • YYAI N/A
  • EPS Growth
  • OCEA N/A
  • YYAI N/A
  • EPS
  • OCEA N/A
  • YYAI N/A
  • Revenue
  • OCEA N/A
  • YYAI N/A
  • Revenue This Year
  • OCEA N/A
  • YYAI N/A
  • Revenue Next Year
  • OCEA N/A
  • YYAI N/A
  • P/E Ratio
  • OCEA N/A
  • YYAI N/A
  • Revenue Growth
  • OCEA N/A
  • YYAI N/A
  • 52 Week Low
  • OCEA $0.46
  • YYAI $0.81
  • 52 Week High
  • OCEA $7.79
  • YYAI $53.00
  • Technical
  • Relative Strength Index (RSI)
  • OCEA 40.01
  • YYAI 28.83
  • Support Level
  • OCEA $0.53
  • YYAI $1.16
  • Resistance Level
  • OCEA $0.70
  • YYAI $1.52
  • Average True Range (ATR)
  • OCEA 0.08
  • YYAI 0.21
  • MACD
  • OCEA -0.00
  • YYAI 0.06
  • Stochastic Oscillator
  • OCEA 4.31
  • YYAI 2.38

About OCEA Ocean Biomedical Inc.

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

Share on Social Networks: